Back

Comparative efficacy of colchicine and intensive LDL-C lowering in patients with ASCVD receiving statins: a network meta-analysis of randomised controlled trials

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Dyslipidaemia: novel diagnostics and therapy options Secondary Prevention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Zhenhong Ou

Chongqing General Hospital, Chongqing University, Chongqing (China)

5 More presentations in this session

Presentation thumbnail
Deciphering lipoprotein(a) atherogenicity with use of high-throughput proteomics
Doctor J. Morze (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
The upfront lipid-lowering combination therapy of statins and ezetimibe vs statin monotherapy in the reduction of cardiovascular outcomes. A meta-analysis.
Professor M. Banach (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Contemporary LDL-cholesterol management in male and female patients at high-cardiovascular risk: results from the European observational SANTORINI study
Professor D. Nanchen (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
The change of paradigm: high HDL-c levels could not mean a long lifespan
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Interleukin-6 signalling, lipoprotein (a) lowering and cardiovascular disease: a mendelian randomisation study
Doctor S. Brennan (Dublin, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Dyslipidaemia: novel diagnostics and therapy options
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Making personalised prevention everyone's business
thumbnail
Congress Presentation
Should we intervene early in patients with asymptomatic aortic stenosis?
thumbnail
Congress Presentation
Cardiovascular prevention in older adults

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources